Department of Health
Six companies will each receive a share of $3.75 million in funding and expert, hands-on support through the to develop their commercial potential.
This investment will help turn their promising digital technologies into real treatments such as:
- a brain imaging analysis platform that uses artificial intelligence (AI) to better monitor and manage neurological diseases like dementia
- AI-driven medical imaging software to unlock personalised treatment options for people with cardiovascular disease
- digital scanning technology and software to create personalised, medical-grade compression garments for therapeutic uses.
received $19.75 million to support small to medium companies to develop technologies with commercial potential through the MRFF’s .
Read the
/Media Release. View in full .
